Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Arctos NorthStar Acquisition logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Key Stats

Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arctos NorthStar Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on sports, media, and entertainment sectors. The company was founded in 2020 and is based in Dallas, Texas.

Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
Last time you’ll see this priced at $1.00
When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!
Northstar California Resort
Arctos Northstar Acquisition Corp
See More Headlines

ANAC Stock Analysis - Frequently Asked Questions

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) posted its quarterly earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by $0.01. The business's revenue was up 14.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arctos NorthStar Acquisition investors own include Portola Pharmaceuticals (PTLA), Micron Technology (MU), Bristol-Myers Squibb (BMY), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Last Earnings
5/10/2016
Today
12/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
CUSIP
03242010
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$7.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.18 per share
Book Value
($0.63) per share

Miscellaneous

Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ANAC) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners